This review summarizes advances in natural-product-based nanomaterials, highlighting their efficacy in acute lung injury treatment and implications for improved drug delivery.
Key Points
Natural-product-based nanomaterials show potential in treating acute lung injury, enhancing drug delivery and reducing side effects.
Research indicates NP-NMs can significantly modulate inflammation and improve clinical outcomes for patients with ALI.
Challenges remain in standardizing synthesis methods and conducting comprehensive evaluations for NP-NMs’ clinical application.
Developing NP-NMs could lead to more effective treatments for acute lung injury, addressing the limitations of current therapies.